Variable response to oral converting enzyme blockade in hypertensive scleroderma patients Academic Article Article uri icon

Overview

MeSH Major

  • Adrenal Gland Neoplasms
  • Carcinoid Tumor
  • Catecholamines
  • Pheochromocytoma

abstract

  • Twelve scleroderma patients with hypertension, seven of whom had malignant hypertension and renal failure of scleroderma renal crisis, were treated with captopril. The first dose lowered mean pressure in all patients by 21.3 mmHg; in 6 patients it relieved encephalopathy. Blood pressure was controlled in all patients. Two of 7 patients with scleroderma renal crisis had improvement in renal function; the 5 patients who did not have malignant hypertension improved or stabilized. Despite good pressure control, however, renal failure developed in 5 patients with scleroderma renal crisis. The data indicated that captopril is effective antihypertensive therapy in scleroderma and, when given early, may prevent renal failure and death.

publication date

  • January 1980

Research

keywords

  • Academic Article

Identity

PubMed ID

  • 6279117

Additional Document Info

start page

  • 241

end page

  • 8

volume

  • 23

number

  • 6